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Abstract  14 
Background: The objective of this study was to investigate the associations between 15 
sedentary behaviour patterns and cardiometabolic risk in children using a monitor that 16 
accurately distinguishes between different postures. Methods: In this cross-sectional study, 17 
118 children (67 girls) aged 11-12-years had adiposity, blood pressure, lipids and glucose 18 
measured and then wore an activPAL device to record sitting, standing and stepping for seven 19 
consecutive days. Data was analysed using multiple linear regression. Results: After 20 
adjustment for potential confounders and moderate-to-vigorous physical activity, the number 21 
of breaks in sitting was significantly negatively associated with adiposity (standardised β≥-22 
0.546; p≤0.001) and significantly positively associated with high-density lipoprotein cholesterol 23 
(HDL) (β=0.415; p≤0.01). Time in prolonged sitting bouts was significantly negatively 24 
associated with adiposity (β≥-0.577; p≤0.001) and significantly positively associated with HDL 25 
(β=0.432; p≤0.05). Standing time was significantly negatively associated with adiposity (β≥-26 
0.270; p≤0.05) and significantly positively associated with HDL (=0.312; p≤0.05). Conclusions: 27 
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This study suggests that increasing the number of breaks in sitting and increasing standing 28 
time are beneficially associated with cardiometabolic risk and should be considered in health 29 
promotion interventions in children. 30 
 31 
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Background 32 
Cardiometabolic disease is an uncommon occurrence or cause of death in children. However, 33 
cardiometabolic risk markers such as obesity, high blood pressure, adverse lipid profile and 34 
impaired glucose levels can begin to develop in childhood, increasing the likelihood of 35 
cardiometabolic disease in adulthood1,2. A clustering of these risk markers in childhood confers 36 
significantly greater risk of Type 2 diabetes mellitus and cardiovascular disease in adult years3 37 
and it is therefore important that appropriate interventions are identified to reduce 38 
cardiometabolic risk marker levels in children.  39 
Sedentary behaviour is defined as any waking behaviour characterised by an energy 40 
expenditure of ≤ 1.5 Metabolic Equivalents (METs) whilst in a sitting, reclining or lying posture4. 41 
It has been reported that children aged 10-14 years old engage in approximately 7–8 hours of 42 
objectively measured sedentary time each day5,6 and may spend up to 80% of their waking 43 
day being sedentary7. However, some previous studies have reported that total sedentary time 44 
was not associated with cardiometabolic risk in 6-19-year-old children8,9. Conversely, other 45 
studies have reported that total sedentary time was significantly negatively correlated with 46 
abdominal adiposity in 10-14-year-old children10 and inversely associated with high-density 47 
lipoprotein cholesterol (HDL) in overweight and obese 5-10-year-olds11. In 9-10 and 15-16-48 
year-old children, total sedentary time was also adversely associated with blood pressure, 49 
fasting glucose, triglycerides, insulin and a clustered cardiometabolic risk score12. The 50 
associations of total sedentary time with cardiometabolic risk reported in the literature is thus 51 
inconclusive. 52 
It has been proposed that the manner in which sedentary time is accumulated may 53 
be associated with cardiometabolic risk, independent of total sedentary time13. However, 54 
there has been only a limited number of studies that have explored associations between 55 
sedentary behaviour patterns and cardiometabolic risk in children and the findings have 56 
provided contradictory results8-10,14,15. For instance, in 10-13-year-old children, accumulated 57 
time in prolonged sedentary bouts (≥ 30 minutes) was positively associated with body mass 58 
index (BMI) and negatively associated with triglycerides14. These findings were supported by 59 
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a study in 10-14-year-old children which observed that an increased number of prolonged 60 
sedentary bouts per day was associated with higher odds of hypertriglyceridemia and 61 
increased clustered cardiometabolic risk10. There is also evidence that the number of breaks 62 
in sedentary time per day was negatively associated with a clustered cardiometabolic risk 63 
score and BMI Z-score in 8-11-year-olds16. However, other studies have reported that time 64 
accumulated in prolonged sedentary bouts was not associated with cardiometabolic risk 65 
markers in 6-19-year-old children8,9. Furthermore, no association was found between the 66 
number of breaks per day and cardiometabolic risk in 10-14-year-old children, although the 67 
mean duration of the breaks in sedentary time was associated with lower odds of abdominal 68 
obesity and elevated diastolic blood pressure (DBP)10.16 The inconclusive findings with 69 
respect to the association between sedentary behaviour patterns and cardiometabolic risk in 70 
children may be a result of measuring sedentary time using accelerometers that are unable 71 
to detect postural allocation. Therefore, standing time could be misclassified as 72 
sitting8,14,15,17,18. This is problematic as it may lead to overestimations of sedentary time and 73 
underestimations of breaks in sedentary time, which may affect the observed associations 74 
with health outcomes19.  75 
To the authors’ knowledge, there are currently no studies that have explored the 76 
associations between objectively measured sedentary behaviour patterns using inclinometry 77 
(that permits detection of postural allocation) and cardiometabolic risk in children. The 78 
objective of this study, therefore, was to investigate the associations between sedentary 79 
behaviour patterns and cardiometabolic risk in children using the activPAL device that 80 
accurately distinguishes between sitting and standing. It was hypothesised that higher total 81 
daily sitting time and a lower number of breaks in sitting would be associated with increased 82 
cardiometabolic risk marker levels. 83 
 84 
Methods 85 
Study design 86 
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This was a cross-sectional study design across schools in Bedfordshire, UK. Data collection 87 
took place in spring 2017 and the study was approved by the University of Bedfordshire 88 
Institute for Sport and Physical Activity Research Ethics Committee (approval number 89 
2017ISPAR001). Other than measurement of sitting, standing and stepping, all other 90 
measures took place at the children’s schools. 91 
 92 
Participants 93 
Participants were 11-12-year-old schoolchildren recruited on a voluntary basis. Volunteers 94 
were excluded from the study if they had any known blood borne disease, had clinically 95 
diagnosed diabetes, were taking glucose-lowering and/or lipid-lowering medication, smoking, 96 
hypertension, major illness/injury, or other health issues that could affect the associations 97 
being assessed in the study. Written parental/guardian informed consent was obtained and 98 
verbal assent obtained from the participants before any test procedures.  99 
 100 
Recruitment 101 
Seventeen middle schools within Bedford Borough and surrounding areas were contacted by 102 
telephone and email to discuss their willingness and availability to help facilitate the study. 103 
Four state schools with mixed gender students agreed to take part in the study. A presentation 104 
during class or assembly time was given by the research team to year groups who were 105 
eligible for the study. This provided an opportunity for children and teachers to ask questions 106 
and for information sheets, health screening questionnaires and consent forms to be 107 
distributed to children to take home to their parents/guardians to be completed. Following this, 108 
schools were asked to send reminders via their text message or email system to parents to 109 
complete and return the forms. Participants received a £5 shopping gift voucher for returning 110 
their activPAL device. 111 
 112 
Measurements 113 
Biological maturity and socioeconomic status 114 
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Biological maturity was self-reported using the Tanner scale20 and Indices of Multiple 115 
Deprivation (IMD) scores were calculated using participants’ home postcodes (self-reported 116 
by parent/guardian) as a measure of socioeconomic status21. 117 
 118 
Anthropometry and body composition 119 
Standing height was measured to the nearest 0.1 cm using a transportable stadiometer (Seca, 120 
Hamburg, Germany). Body mass was measured to the nearest 0.1 kg and body fat% 121 
estimated by bioelectrical impedance analysis to the nearest 0.1% using the Tanita BC-418 122 
MA Segmental Body Composition Analyzer (Tanita Corp., Tokyo, Japan). Body fat% was 123 
estimated using manufacturer prediction equations that are based on gender, age, body mass, 124 
height and impedance. BMI was calculated as: BMI = body mass (kg) ÷ height (m2). BMI z-125 
score was calculated using UK reference values22. Waist circumference (WC) was measured 126 
using an adjustable tape measure (HaB Direct, Southam, UK) to the nearest 0.1 cm at the 127 
level of the umbilicus following gentle expiration10.  128 
 129 
Blood pressure, lipids and glucose 130 
Following 5 minutes of rest in a seated position, resting blood pressure was measured on the 131 
left arm using an Omron M5-I automatic blood pressure monitor (Omron Matsusaka Co Ltd., 132 
Matsusaka, Japan). Two measures were taken with a two-minute rest between each and the 133 
average recorded. Fasting whole blood samples were obtained (100 µl) via a finger prick 134 
method and analysed using the Cholestech LDX Analyzer (Cholestech Corp., Hayward, CA.) 135 
to provide measures of total cholesterol (TC), high-density lipoprotein cholesterol (HDL), low-136 
density lipoprotein cholesterol (LDL), triglycerides, non-HDL, TC:HDL ratio and glucose. This 137 
system has been validated in adults23 and has been used in previous paediatric research10,24. 138 
A continuous clustered cardiometabolic risk score was calculated by summing the z-scores 139 
for WC, DBP, TC:HDL ratio, triglycerides and glucose10. A non-obesity clustered 140 
cardiometabolic risk score was calculated by summing the z-scores for DBP, TC:HDL ratio, 141 
triglycerides and glucose12. These clustered risk scores were calculated as they provide 142 
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greater statistical power25, account for daily variations in individual risk markers and have 143 
previously been used in paediatric research10,12,16 Impaired fasting glucose was defined as ≥ 144 
5.6 mmol · L-126. Hypercholesterolemia was defined as ≥ 5.17 mmol · L-127. Triglycerides were 145 
considered high between 1.02 – 1.46 mmol · L-1 and HDL considered low between 0.91 – 1.16 146 
mmol · L-127. The present study defined hypertriglyceridemia as ≥ 1.24 mmol · L-1 and low HDL 147 
as ≤ 1.03 mmol · L-1 as this is the mid-point between these ranges10,28. 148 
 149 
Sitting, standing and stepping 150 
Participants were asked to wear an activPAL device (PAL technologies, Glasgow, Scotland) 151 
continuously for seven consecutive days following the data collection session. Participants 152 
completed a diary to record what time they woke up, got out of bed, what time they went to 153 
bed, went to sleep and timings of any periods during the day when the monitor was removed.  154 
The monitor was wrapped in a nitrile flexible sleeve to protect it from water and fitted to the 155 
mid anterior aspect of the right thigh with a hypo-allergenic transparent film roll (Hypafix, 156 
BSNmedical, UK). The activPAL measures bodily accelerations and identifies postural 157 
changes depending on the inclination of the wearer’s thigh29. The monitor categorises each 158 
15 s epoch as sitting/lying, standing or stepping30. The activPAL monitor provides reliable and 159 
valid measures of time spent sitting/lying, standing, stepping, sit-to-upright and upright-to-sit 160 
transitions in children31. 161 
Periods and patterns of sitting (total sitting time, prolonged sitting bouts and breaks in 162 
sitting time), standing, light stepping (i.e. light physical activity) and moderate-to-vigorous 163 
stepping (i.e. moderate-to-vigorous physical activity [MVPA]) were determined using an 164 
automated algorithm developed for use with Stata (StataCorp LLC, Texas, US)32. Inclusion 165 
criteria for valid wear time was a minimum of four days including at least one weekend day29. 166 
A valid day was required to have a minimum of 10 hours wear time and >500 steps29,32. A 167 
prolonged sitting bout was defined as a period ≥30 minutes in a sitting/reclining posture 168 
during waking time in line with previous studies8,14. A break in sitting was defined as a non-169 
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sitting period in between two sitting bouts33.  All variables were calculated for each valid day 170 
and then averaged across all included valid days for analysis.  171 
 172 
Statistical analysis 173 
SPSS v23.0 (SPSS Inc., Armonk, N.Y., USA) was used for all statistical analysis. Skewness 174 
and kurtosis in addition to visual inspection of Q-Q plots were used to check normality of the 175 
data. Variables that were non-normally distributed were log transformed prior to analysis, 176 
which included weight, BMI, WC and TC:HDL ratio. Descriptive data is presented as mean ± 177 
SD. Multiple linear regression was used to assess associations between sitting, standing and 178 
stepping variables (i.e. total sitting time, number of breaks in sitting per day, total time spent 179 
in prolonged sitting bouts, standing time and light physical activity) with cardiometabolic risk 180 
marker levels. Sex, IMD scores, biological maturity, school attended, and activPAL wear time 181 
were significantly correlated with ≥1 cardiometabolic risk marker and were thus adjusted for 182 
in the analysis (model 1). In model 2, these covariates were entered in addition to moderate-183 
MVPA to explore whether MVPA mediates any of the associations between sitting, standing 184 
and light physical activity variables and cardiometabolic risk markers. The level of significance 185 
was accepted at p≤0.05. 186 
 187 
Results 188 
Of the 610 information sheets distributed across four schools, 148 participants returned 189 
consent forms, of which 20 participants withdrew from the study prior to data collection.  Ten 190 
participants did not provide valid activPAL data (six did not meet wear time criteria, two devices 191 
malfunctioned, and two devices were not returned) and thus were excluded from the analysis. 192 
A total of 118 participants (67 girls) were included in the present analysis. Three participants 193 
(two girls) withdrew from the blood sampling during the measurement morning, thus 115 194 
participants were included for analyses of blood markers. 195 
Anthropometric and cardiometabolic risk marker descriptive characteristics are shown 196 
in Table 1. The prevalence of abdominal obesity in the whole sample was 37.3% (n=44), 197 
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elevated systolic blood pressure (SBP) 2.6% (n=3), and elevated DBP 3.4% (n=4). From the 198 
115 participants that provided blood samples, the prevalence of hypercholesterolemia was 199 
41.7% (n=48), hypertriglyceridemia 28.7% (n=33), low HDL 4.4% (n=5) and impaired fasting 200 
glucose 6.1% (n=7).  The proportion of the sample meeting the government recommended 60 201 
minutes/day of MVPA 34 was 91.5 ± 0.4%. 202 
Sitting, standing and physical activity descriptives are shown in Table 2. Associations 203 
within both regression models are shown in Table 4 and Table 5 (the latter additionally 204 
adjusting for MVPA). Due to high collinearity with wear time, total sitting time was removed 205 
from the analysis in both regression models.  In both regression models the number of breaks 206 
in sitting per day was significantly negatively associated with weight, BMI, WC and body fat% 207 
and significantly positively associated with TC and HDL. Total time spent in prolonged sitting 208 
bouts was significantly negatively associated with weight, BMI, WC and body fat% and 209 
significantly positively associated with TC and HDL in both regression models.  In regression 210 
model 1, total time spent in prolonged sitting bouts was significantly positively associated with 211 
LDL and non-HDL, however, this was attenuated in regression model 2 and became non-212 
significant. 213 
In regression model 1, standing time was significantly negatively associated with 214 
weight and body fat% and significantly positively associated with HDL. In regression model 2, 215 
standing time remained significantly negatively associated with weight and body fat% and 216 
significantly positively associated with HDL. Standing time became significantly negatively 217 
associated with WC in model 2. Light physical activity was significantly negatively associated 218 
with body fat% in regression model 1, however, this association was weakened when MVPA 219 
was additionally adjusted for in regression model 2 and became non-significant. 220 
 221 
Discussion 222 
The main findings of this study were that the number of breaks in sitting and the time in 223 
prolonged sitting bouts are significantly negatively associated with adiposity and significantly 224 
positively associated with HDL and TC in 11-12-year-old children. The significant negative 225 
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association of time in prolonged sitting with weight, BMI, WC and body fat% in present study 226 
was unexpected, as this suggests that children who spend longer periods of time engaging in 227 
prolonged sitting had reduced adiposity levels. Conversely, Altenburg et al. 14 found that time 228 
spent in prolonged sedentary bouts (≥ 30 minutes) was significantly positively associated with 229 
BMI, but not WC, in children aged 10-13 years old. Participants in the study by Altenburg et 230 
al. 14 had a similar mean BMI to the participants in the present study but also had a lower WC, 231 
which could explain some of the variation in results. Furthermore, the participants in the 232 
current study were highly active and it is thus possible that prolonged sitting is not 233 
unfavourably associated with adiposity in highly active children. Time in prolonged sitting bouts 234 
was significantly positively associated with HDL in the present study, which was also 235 
unexpected. This could have been confounded by dietary intake35,36, which was not accounted 236 
for in the present study whereby those who engaged in more prolonged sitting consumed a 237 
diet that encourages higher levels of HDL. Alternatively, prolonged sitting may not be 238 
detrimentally associated with HDL, which is supported by previous research10. In the present 239 
study, time in prolonged sitting bouts was significantly positively associated with TC, which 240 
may be due to the higher levels of HDL in participants who engaged in more prolonged sitting 241 
time. Altenburg et al. 14 found no significant association between time in prolonged sedentary 242 
bouts and TC in children aged 10-13 years. This discrepancy could be due to the low volume 243 
of uninterrupted prolonged sedentary time accumulated in the study by Altenburg et al. 14 (32 244 
minutes/day) compared to the present study (265 minutes/day). The associations between 245 
prolonged sitting with adiposity and lipids thus remains unclear and longitudinal studies should 246 
be conducted to examine causal relationships and to establish if prolonged sitting should be 247 
considered an intervention target for health promotion in children. 248 
In the present study, time spent in prolonged sitting bouts was significantly positively 249 
associated with LDL and non-HDL, however, this association was attenuated by MVPA. This 250 
suggests that MVPA may protect against high levels of LDL in children who spend more time 251 
in prolonged sitting bouts. However, the beneficial association between the number of breaks 252 
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in sitting and HDL was independent of MVPA and children should thus be encouraged to 253 
engage in more breaks regardless of their MVPA levels.   254 
The number of breaks in sitting was significantly negatively associated with weight, 255 
BMI, WC and body fat%. A longitudinal study in children at age 7, 9, 12 and 15 years old 256 
supports these findings in which more breaks in sedentary time between the ages of 9-12 257 
years was significantly associated with a decrease in fat mass index and BMI37. However, the 258 
number of breaks in sitting was significantly positively associated withTC in the present study, 259 
which may be because higher levels of HDL were seen with an increased number of breaks 260 
without any change in LDL. In children aged 8-11 years old, breaks in sedentary time was 261 
significantly associated with reduced clustered cardiometabolic risk score and BMI z-scores16. 262 
This is similar to the present study for BMI but conflicting with regards to no association 263 
between breaks and clustered cardiometabolic risk score. This may be because children in 264 
the study by Saunders et al. 16 had a higher BMI and clustered cardiometabolic risk score, 265 
which could strengthen the associations observed due to poorer metabolic health. Based on 266 
this evidence, it may be appropriate for interventions to target increases in the number of 267 
breaks in sedentary time to reduce cardiometabolic risk in children. 268 
The present study is the first, to the authors’ knowledge, to evaluate the association of 269 
standing time with cardiometabolic risk in children. Standing time was significantly negatively 270 
associated with weight and body fat% and positively associated with HDL, independent of 271 
MVPA. Increased standing time may elicit a greater daily energy expenditure, thus decreasing 272 
excess energy that could be stored as fat. Nonetheless, standing time became significantly 273 
negatively associated with WC when adjusting for MVPA, which suggests that the association 274 
between standing and WC is mediated by MVPA. The findings suggest that standing may be 275 
beneficially associated with adiposity in children and it may thus be appropriate to encourage 276 
more opportunities to stand throughout the day, such as in the classroom. However, further 277 
research is needed to establish causal effects of increases in standing time on adiposity to 278 
inform public health interventions.  279 
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In this study, children accumulated 553 minutes (9.2 hours) of sitting per day. Although 280 
no previous studies have measured sitting time in children, the daily sitting time reported in 281 
the present study is higher than the 504 minutes per day of sedentary time reported in a 282 
previous UK study10. It is also higher than that reported by Colley et al. 9 in Canadian children 283 
aged 11-14 years old in which boys accumulated 508 minutes and girls 524 minutes per day. 284 
However, the higher sitting time in girls (529 min/day vs. 514 min/day in boys) in the present 285 
study is consistent with this previous study9. Children in Europe aged 10-14 years old engaged 286 
in approximately 7-8 hours of objectively measured sedentary time each day5,6, which is 287 
markedly lower than in the present study. This could be due to samples being recruited from 288 
different regions or that the use of the activPAL inclinometer may have been more sensitive 289 
to detecting sedentary time than previously used accelerometers31. Consistent across studies, 290 
though, is that children accumulate relatively high amounts of daily sedentary time and public 291 
health interventions may be needed to reduce sedentary time in young populations. 292 
The present study found that children aged 11-12 years old spent an average of 265 293 
minutes in prolonged sitting bouts (≥ 30 minutes) per day, which was approximately half of 294 
their total sitting time. This is similar to the findings of Bailey et al. 10 who reported that children 295 
aged 10-14 years old spent 260 minutes in prolonged bouts of ≥ 20 minutes, but higher than 296 
that found by Carson and Janssen 8 who reported 204 minutes in prolonged sedentary bouts 297 
of ≥ 30 minutes in 6-19 year-olds. It thus appears that the children in the present sample 298 
engaged in more prolonged sedentary time than previous studies. However, a potential reason 299 
for the discrepancies could be differences in the age of the samples or different devices and 300 
thresholds used to define sedentary/sitting time. Future studies should therefore consider 301 
developing a universal approach for measurement and classification of sedentary time in 302 
children to establish the time they spend in prolonged sitting. Nonetheless, this data suggests 303 
that strategies may be needed to reduce prolonged sitting in the paediatric population. 304 
The mean number of breaks in sitting was 81 per day, which is similar to results found 305 
in children aged 6-19 years old who engaged in 83 breaks per day9. Bailey et al. 10 found that 306 
children aged 10 -14 years old engaged in 63 breaks per day. A reason for the lower number 307 
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of breaks observed previously could be the use of an accelerometer that did not differentiate 308 
between postures and may have misclassified standing time as sitting that would have been 309 
classified as a break in the current study38. In addition, Bailey et al. 10 used a 1-min epoch 310 
length, which is longer than the 15 s epoch used in the present study but the same as used 311 
by Colley et al. 9. Due to children’s sporadic and intermittent behaviour17, the longer epoch 312 
may not capture all breaks between shorter periods of sedentary time. Despite children in the 313 
present study breaking up their sedentary time 81 times per day, approximately half of their 314 
total sitting time was spent in prolonged bouts, meaning that these breaks were not evenly 315 
spread throughout the day. Future research should identify segments of the day when children 316 
engage in prolonged sitting (e.g. during class time, break time or at home) to inform 317 
appropriate interventions. 318 
The main strength of this study was the use of a validated device for measurement of 319 
sitting, standing and stepping. In addition, a wide array of cardiometabolic risk markers were 320 
measured to provide an in-depth exploration of their association with sitting behaviour 321 
patterns. However, the study was a cross-sectional design, which limits conclusions regarding 322 
causality and the sample size is small limiting generalisability of the findings. The children in 323 
this study were also generally normal weight and highly active. The findings thus cannot be 324 
generalised to other population groups. Researchers are thus encouraged to investigate the 325 
associations of sitting behaviour patterns with cardiometabolic risk in overweight and obese 326 
children as well as children with low activity levels as these populations may have increased 327 
cardiometabolic risk that may be more strongly associated with sitting time. The sample was 328 
also of a narrow age range and further research should be conducted in other age groups 329 
using combined accelerometry and inclinometry methods.   330 
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Conclusions 331 
This study provides evidence that an increased number of breaks in sitting and daily standing 332 
time are beneficially associated with cardiometabolic risk in 11-12-year-old children, 333 
independent of MVPA. However, the association between prolonged sitting and 334 
cardiometabolic risk markers was mixed. Although longitudinal and experimental studies are 335 
required to determine cause and effect relationships between sitting behaviour patterns and 336 
cardiometabolic risk, these findings suggest that increasing breaks from sitting and increasing 337 
standing time may be potential intervention strategies to improve cardiometabolic health in 338 
children. 339 
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Table 1. Anthropometric and cardiometabolic risk marker descriptives 456 
 All (n=118) Boys (n=51) Girls (n=67) 
Height (cm) 154.3 ± 7.2 153.4 ± 6.6 154.9 ± 7.5 
Weight (kg) 45.3 ± 11.3 43.7 ± 10.4 46.5 ± 11.9 
Body mass index (kg/m2) 18.9 ± 3.9 18.5 ± 3.5 19.3 ± 4.4 
Body mass index z-score 0.01 ± 1.02 -0.12 ± 0.89 0.10 ± 1.10 
Body fat% 23.3 ± 7.1 21.3 ± 6.9 24.9 ± 6.9 
Waist circumference (cm) 67.3 ± 10.1 67.6 ± 9.0 67.0 ± 10.9 
Systolic blood pressure (mmHg) 104 ± 10.93 101 ± 11.17 107 ± 10.18 
Diastolic blood pressure (mmHg) 67 ± 7.62 65 ± 7.41 68 ± 7.64 
Total cholesterol (mmol · L-1) 5.94 ± 2.79 5.76 ± 2.65 6.08 ± 2.90 
HDL (mmol · L-1) 2.12 ± 1.08 2.18 ± 1.08 2.07 ± 1.08 
Triglycerides (mmol · L-1) 1.50± 1.53 1.26 ± 1.30 1.68 ± 1.67 
LDL (mmol · L-1) 3.36 ± 1.76 3.21 ± 1.61 3.47 ± 1.87 
Non-HDL (mmol · L-1) 3.82 ± 1.93 3.59 ± 1.74 3.99 ± 2.05 
TC:HDL ratio 2.93 ± 0.80 2.72 ± 0.46 3.09 ± 0.95 
Glucose (mmol · L-1) 4.96 ± 0.49 4.93 ± 0.43 4.98 ± 0.53 
Clustered risk score 0.01 ± 3.08 -0.54 ± 2.46 0.44 ± 3.44 
Non-obesity clustered risk score 0.56 ± 2.58 -0.59 ± 2.03 0.55 ± 2.85 
Data presented as mean ± SD. 457 
HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; TC, total 458 
cholesterol. 459 
n=115 for blood parameters.  460 
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Table 2. Sitting, standing and stepping descriptives 461 
 All (n=118) Boys (n = 51) Girls (n = 67) 
activPAL weartime (minutes/day) 849.91 ± 42.6 852.00 ± 42.6 848.40 ± 42.6 
Total sitting time (minutes/day) 522.60 ± 67 513.60 ± 1.13 529.20 ± 52.3 
Standing time (minutes/day) 177.00 ± 39.6 165.60 ± 45.6 185.40 ± 31.8 
Light physical activity (minutes/day) 60.60 ± 15 69.60 ± 13.2 54.00 ± 12.6 
MVPA (minutes/day) 90.00 ± 24 103.20 ± 22.2 79.80 ± 19.8 
Number of breaks in sitting per day 81.32 ± 11.50 82.71 ± 17.66 80.26 ± 19.17 
Number of prolonged sitting bouts 3.7 ± 1.2 3.6 ± 1.4 3.8 ± 1.1 
Time spent in prolonged sitting bouts 
(minutes/day) 
265.91 ± 93 262.63 ± 107.4 268.42 ± 81.6 
Data presented as mean ± SD. 462 
MVPA, moderate-to-vigorous physical activity 463 
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Table 3. Associations of sitting variables, standing and light physical activity with cardiometabolic risk markers in 11-12-year-old 464 
children (Model 1) 465 
Standardised beta values from multiple regression. Data are standardised regression coefficients (95% CI). All outcomes are adjusted for sex, 466 
IMD score, school and Tanner stage, total sedentary time and weartime. 467 
a log-transformed         468 
*p≤0.05          **p≤0.01          ***p≤0.001           469 
 Standing time (minutes/ 
day)  
Light physical activity 
(minutes/ day) 
Number of breaks in 
sedentary time per day 
Total time in prolonged 
sedentary bouts 
(minutes/day) 
Weighta (kg) -.253 (-.074, -.001)* -.141 (-.156, .049) -.591 (-.005, -.002)*** -.590 (-.057, -.016)*** 
BMIa (kg/m2) -.150 (-.049, .013) -.149 (-.133, .041) -.526 (-.004, -.001)*** -.581 (-.047, -.012)*** 
WCa (cm) -.252 (-.048, .001) -.084 (-.089, .050) -.514 (-.003, -.001)** -.473 (-.032, -.004)* 
Body Fat% -.274 (-5.615, -.260)* -.310 (-16.012, -.934)* -.497 (-.299, -.075)*** -.624 (-4.300, -1.265)*** 
Systolic Blood Pressure (mmHg) .097 (-2.742, 6.013) -.098 (-16.550, 8.100) -.177 (-.288, .077) -.151 (-3.534, 1.411) 
Diastolic Blood Pressure (mmHg) -.056 (-2.603, 3.932) -.021 (-9.839, 8.563) -.070 (-.165, .108) .037 (-1.664, 2.027) 
TC (mmol · L-1) .241 (-.023, 2.041) -.051 (-3.538, 2.428) .343 (.007, .095)* .421 (.126, 1.348)* 
HDL (mmol · L-1) .309 (.115, .898)* -.152 (-1.786, .479) .404 (.007, .040)** .417 (.054, .518)* 
Triglycerides (mmol · L-1) .151 (-.290, 1.002) -.145 (-2.760, .974) .186 (-.012, .043) .134 (-.250, .515) 
LDL (mmol · L-1) .162 (-.249, 1.103) .032 (-1.733, 2.175) .264 (-.004, .054) .374 (.011, .811)* 
Non-HDL (mmol · L-1) .178 (-.235, 1.263) .005 (-2.128, 2.201) .272 (-.004, .060) .376 (.011, .898)* 
TC:HDLa -.119 (-.064, .026) .157 (-.063, .196) -.145 (-.003, .001) -.021 (-.028, .025) 
Glucose (mmol · L-1) .163 (-.077, .320) -.228 (-1.022, .126) .148 (-.005, .012) .339 (-.012, .223) 
Clustered risk score -.002 (-1.341, 1.321) -.105 (-5.145, 2.551) -.130 (-.079, .035) .003 (-.783, .793) 
Non-obesity clustered risk score .078 (-.801, 1.418) -.100 (-4.244, 2.170) .008 (-.046, .049) .137 (-.430, .883) 
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BMI, body mass index; WC, waist circumference; TC, total cholesterol; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein 470 
cholesterol; non-HDL, non-high-density lipoprotein cholesterol; TC:HDL, total cholesterol to high-density lipoprotein cholesterol ratio.  471 
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Table 4. Associations of sitting variables, standing and light physical activity with cardiometabolic risk markers in 11-12-year-old 472 
children additionally adjusting for moderate-to-vigorous physical activity (Model 2) 473 
 474 
Standardised beta values from multiple regressions. Data are standardised regression coefficients (95% CI). All outcomes are adjusted for sex, 475 
IMD score, school and Tanner stage, total sedentary time, weartime and moderate-to-vigorous physical activity.   476 
a log-transformed  b Different from Partially adjusted regression model   477 
*p≤0.05  **p≤0.01          ***p≤0.001         478 
BMI, body mass index; WC, waist circumference; TC, total cholesterol; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein 479 
cholesterol; non-HDL, non-high-density lipoprotein cholesterol; TC:HDL, total cholesterol to high-density lipoprotein cholesterol ratio.   480 
 Standing time (minutes/ 
day)  
Light physical activity 
(minutes/ day) 
Number of breaks in 
sedentary time per day  
Total time in prolonged 
sedentary bouts (minutes/ 
day) 
Weighta (kg) -.270 (-.076, -.004)*  -.013 (-.118, .109)  -.661 (-.005, -.002)*** -.678 (-.063, -.021)*** 
BMIa (kg/m2) -.168 (-.051, .010)  -.012 (-.100, .093)  -.601 (-.004, -.001)*** -.675 (-.052, -.016)*** 
WCa (cm) -.272 (-.049, -.001)* b .069 (-.060, .093)  -.597 (-.003, -.001)*** -.577 (-.036, -.008)*** 
Body Fat% -.286 (-5.741, -.388)*  -.220 (-14.447, 2.424) b -.546 (-.321, -0.90) *** -.685 (-4.629, -1.495)*** 
Systolic Blood Pressure (mmHg) .090 (-2.882, 5.921)  -.046 (-15.855, 11.887) -.206 (-.312, .067) -.186 (-3.889, 1.265) 
Diastolic Blood Pressure (mmHg) .072 (-2.406, 4.104) -.140 (-14.476, 6.041) -.005 (-.142, .138) .118 (-1.325, 2.487) 
TC (mmol · L-1) .239 (-.045, 2.041)  -.037 (-3.755, 2.947) .334 (.003, .096)*   .410 (.070, 1.363)*  
HDL (mmol · L-1) .312 (.116, .907)*  -.169 (-2.000, .543)  .415 (.007, .042)**  .432 (.051, .542)*  
Triglycerides (mmol · L-1) .137 (-.328, .971) -.067 (-2.499, 1.673) .134 (-.018, .040) .069 (-.335, .470) 
LDL (mmol · L-1) .160 (-.261, 1.105) .043 (-1.899, 2.491) .257 (-.006, .054) .365 (-.022, .824) b 
Non-HDL (mmol · L-1) .172 (-.259, 1.254) .034 (-2.172, 2.688) .253 (-.008, .060) .351 (-.044, .893) b 
TC:HDLa -.129 (-.066, .024) .210 (-.056, .234) -.180 (-.003, .001) -.066 (-.032, .024) 
Glucose (mmol · L-1) .158 (-.082, .319)  -.203 (-1.041, .247) .131 (-.005, .012) .317 (-.025, .223) 
Clustered risk score -.014 (-1.407, 1.275) -.042 (-4.834, 3.783) -.172 (-.088, .031) -.050 (-.930, .732) 
Non-obesity clustered risk score .072 (-.835, 1.406)  -.070 (-4.321, 2.879) -.013 (-.052, .048) .111 (-.511, .878) 
